CEO and President L Daniel Browne sold $204K of Revance Therapeutics, Inc.

Sold$204,148

$31.64Price

6,452Shares

−4%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Thu, Mar 15. Filed Fri, Mar 16, 4:03 PM ET, after the close. Not investment advice.